Yigal Helviz

Yigal Helviz

Auto-generated profile, based on publicly available information

Yigal Helviz

General Intensive Care Unit, Shaare Zedek Medical Center, Jerusalem, Israel

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 March 2019 in Intensive Care Medicine
Verified
Journal Article
Closed access
PDF file
BRB. Rochwerg
B. Rochwerg
DGD. Granton
D. Granton
DWD. X. Wang
D. X. Wang
YHY. Helviz
Y. Helviz
SES. Einav
S. Einav
KBK. Burns
K. Burns

20 March 2018 in Critical Care
Verified
Journal Article
Open access
PDF file
YHYigal Helviz
Yigal Helviz
Sharon EinavSharon Einav
Sharon Einav
This article is one of ten reviews selected from the Annual Update in Intensive Care and Emergency Medicine 2018. Other selected articles can be found online at https://www.biomedcentral.com/collections/annualupdate2018. Further information about the Annual Update in Intensive Care and Emergency Medicine is available from http://www.springer.com/series/8901.

5 June 2019 in Critical Care
Verified
Journal Article
Open access
PDF file
Andrea CortegianiAndrea Cortegiani
Andrea Cortegiani
Claudia CrimiClaudia Crimi
Claudia Crimi
ANAlberto Noto
Alberto Noto
YHYigal Helviz
Yigal Helviz
AGAntonino Giarratano
Antonino Giarratano
Sharon EinavSharon Einav
Sharon Einav

1 November 2019 in Respiratory Care
Verified
Journal Article
Closed access
PDF file
SZSasson Zemach
Sasson Zemach
YHYigal Helviz
Yigal Helviz
MSMichal Shitrit
Michal Shitrit
RFReuven Friedman
Reuven Friedman
PLPhillip D Levin
Phillip D Levin
BACKGROUND: High-flow nasal cannula (HFNC) oxygen therapy is a routine, evidence-based treatment in the ICU. Due to its ease of application, non–evidence-based use of HFNC has spread to non-ICU wards. This study reports on the experience with HFNC outside the ICU. METHODS: This is an observational study of HFNC prescribed by treating physicians in non-ICU areas. Primary outcomes included change in dyspnea visual analog scale score and physiological variables both before and 30 min after initiation of HFNC treatment. Secondary outcomes included mortality, ICU admission, and intubation. RESULTS: We observed decreased median (interquartile range) visual analog scale scores after initiation of HFNC: 8 (6–9) versus 5 (4–6) ( P < .001) in 90 of 111 subjects (81%, 95% CI 72.5–87.9%, P < .001). Breathing frequency (31 ± 10 vs 26 ± 7 breaths/min, P < .001) and saturation (84 ± 12% vs 94 ± 5%, P < .001) also improved. Overall cohort mortality was 55 of 111 subjects (50%); however, 41 of 111 subjects (33%) had a do not resuscitate (DNR) order. Among 70 non-DNR subjects, early mortality (< 72 h) occurred in 9 of 70 subjects (13%), and late mortality in 12 of 70 subjects (17%). The composite end point (ie, discharged alive, non-intubated, not admitted to ICU) was met by 35 of 70 subjects (50%) without a DNR order. An increased ROX index ([S pO 2 /F IO 2 ]/breathing frequency) was the only independent predictor associated with achieving the composite outcome (odds ratio 1.51, 95% CI 1.1–2.0, P = .01). Higher pre-connection visual analog scale score (odds ratio 1.75, 95% CI 1.35–2.28, P < .001) and a history of respiratory disease (odds ratio 3.52, 95% CI 1.27–9.72, P = .01) were predictors of greater improvement in dyspnea with HFNC. No variable predicted mortality. CONCLUSIONS: HFNC outside the ICU was associated with improved visual analog scale score, breathing frequency, and saturation but with a relatively high mortality, even in non-DNR subjects. HFNC was used in many subjects who had a DNR order. This therapy may have been palliative in intent. Care should be exercised in using this therapy in a setting that is not continuously monitored.

7 December 2018 in Intensive Care Medicine
Verified
Journal Article
Open access
PDF file
YHYigal Helviz
Yigal Helviz
MOMarcus Ong
Marcus Ong
Sharon EinavSharon Einav
Sharon Einav

1 June 2015 in Journal of Critical Care
Verified
Journal Article
Closed access
MHMoshe Hersch
Moshe Hersch
VKValery Krasilnikov
Valery Krasilnikov
YHYigal Helviz
Yigal Helviz
SZShoshana Zevin
Shoshana Zevin
PRPetachia Reissman
Petachia Reissman
SESharon Einav
Sharon Einav